{"id":4225,"date":"2025-07-01T12:03:24","date_gmt":"2025-07-01T09:03:24","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=4225"},"modified":"2025-07-01T12:04:57","modified_gmt":"2025-07-01T09:04:57","slug":"humanise-avrupa-birligi-iyi-uretim-uygulamalarindan-tam-not","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=4225","title":{"rendered":"Humanis\u2019e, Avrupa Birli\u011fi \u0130yi \u00dcretim Uygulamalar\u0131\u2019ndan Tam Not\u2026"},"content":{"rendered":"\n

\u0130la\u00e7 \u00fcretiminde kalite, g\u00fcvenilirlik ve s\u00fcrd\u00fcr\u00fclebilirli\u011fi merkezine alan Humanis, Bel\u00e7ika otoritesi taraf\u0131ndan ger\u00e7ekle\u015ftirilen EU-GMP (Avrupa Birli\u011fi \u0130yi \u00dcretim Uygulamalar\u0131) denetimini ba\u015far\u0131yla tamamlad\u0131.<\/strong><\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

\u201cHerkes i\u00e7in s\u00fcrd\u00fcr\u00fclebilir sa\u011fl\u0131k\u201d anlay\u0131\u015f\u0131yla faaliyetlerini s\u00fcrd\u00fcren Humanis, ila\u00e7 \u00fcretiminde kalite ve g\u00fcvenilirlik esaslar\u0131n\u0131 daima en \u00fcst seviyede tutma kararl\u0131l\u0131\u011f\u0131n\u0131 bir kez daha peki\u015ftirdi. Firma, Bel\u00e7ika otoritesi taraf\u0131ndan ger\u00e7ekle\u015ftirilen EU-GMP (Avrupa Birli\u011fi \u0130yi \u00dcretim Uygulamalar\u0131) denetimini ba\u015far\u0131yla tamamlayarak, bu \u00f6nemli s\u00fcre\u00e7ten tam not ald\u0131. Tekirda\u011f \u00c7erkezk\u00f6y\u2019de 108.000 metrekarelik arazi \u00fczerine kurulu, 45.000 metrekare kapal\u0131 alana sahip \u00fcretim tesisinde, y\u0131ll\u0131k 330 milyon kutu ila\u00e7 \u00fcretimi kapasitesi mevcut. 45 \u00fclkeye ihracat yapan Humanis, Avrupa Birli\u011fi kalite standartlar\u0131ndaki \u00fcretim yetkinli\u011fi sayesinde T\u00fcrkiye\u2019 den \u00c7in\u2019 e ila\u00e7 ihracat\u0131 yapan ilk firma olma ba\u015far\u0131s\u0131na sahip.<\/p>\n\n\n\n

\u201cT\u00fcrk t\u0131bb\u0131na katk\u0131 sunman\u0131n gururunu ya\u015f\u0131yoruz\u201d<\/strong><\/p>\n\n\n\n

Humanis Teknik Operasyonlar Genel M\u00fcd\u00fcr\u00fc Fatih Elay, <\/strong>yeni ba\u015far\u0131lar\u0131 i\u00e7in \u015funlar\u0131 s\u00f6yledi: \u201cKaliteli ve g\u00fcvenilirlik \u00fcretim anlay\u0131\u015f\u0131m\u0131z\u0131 kan\u0131tlaman\u0131n, insan odakl\u0131 felsefemiz ile sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri sunma misyonumuzu bir kez daha ortaya koyman\u0131n gururunu ya\u015f\u0131yoruz. Bu s\u00fcre\u00e7te eme\u011fi ge\u00e7en t\u00fcm arkada\u015flar\u0131m\u0131za te\u015fekk\u00fcrlerimi sunuyorum. Avrupa standartlar\u0131ndaki ila\u00e7 \u00fcretimi faaliyetlerimizle global d\u00fczlemde \u00e7ok daha fazla insana sa\u011fl\u0131k \u00e7\u00f6z\u00fcm\u00fc sunmaya devam edece\u011fiz.\u201d<\/p>\n\n\n\n

200\u2019 den fazla \u00fcr\u00fcn ve 100’den fazla molek\u00fcl  ile iyi ya\u015fam\u0131 t\u00fcm d\u00fcnyada eri\u015filebilir k\u0131l\u0131yor.<\/strong><\/p>\n\n\n\n

Sanayi ve Teknoloji Bakanl\u0131\u011f\u0131 taraf\u0131ndan te\u015fvik edilen en b\u00fcy\u00fck be\u015f ila\u00e7 Ar-Ge merkezinden birine sahip olan Humanis, 12 y\u0131ld\u0131r alan\u0131nda \u00f6nemli ba\u015far\u0131lara imza at\u0131yor. QbD (Quality by Design), EMA (Avrupa \u0130la\u00e7 Ajans\u0131) ve ICH (Uluslararas\u0131 Uyum Konseyi) d\u00fczenlemelerine tam uyum sa\u011flamay\u0131 ba\u015faran Humanis Ar-Ge merkezi,  200\u2019 \u00fcn \u00fczerinde ruhsatl\u0131 \u00fcr\u00fcn ve 100’den fazla molek\u00fcl ile iyi ya\u015fam\u0131 t\u00fcm d\u00fcnyada eri\u015filebilir k\u0131l\u0131yor. 2030 y\u0131l\u0131na kadar da firma, merkezi sinir sistemi hastal\u0131klar\u0131, kalp damar hastal\u0131klar\u0131 ve diyabet alanlar\u0131nda \u00fcr\u00fcnler geli\u015ftirerek t\u0131bb\u0131n hizmetine sunmay\u0131 planl\u0131yor.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u0130la\u00e7 \u00fcretiminde kalite, g\u00fcvenilirlik ve s\u00fcrd\u00fcr\u00fclebilirli\u011fi merkezine alan Humanis, Bel\u00e7ika otoritesi taraf\u0131ndan ger\u00e7ekle\u015ftirilen EU-GMP (Avrupa Birli\u011fi \u0130yi \u00dcretim Uygulamalar\u0131) denetimini ba\u015far\u0131yla tamamlad\u0131.<\/p>\n","protected":false},"author":1,"featured_media":4229,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,2],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4225"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4225"}],"version-history":[{"count":2,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4225\/revisions"}],"predecessor-version":[{"id":4230,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4225\/revisions\/4230"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/4229"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}